Timothy Eugene Sullivan - 03 May 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Reporting relationship: Chief Financial Officer
Issuer ticker: APLS
Reported as of: 03 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 May 2023, 16:22:59 UTC
Prior SEC filing: 20 Apr 2023
Next SEC filing: 06 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ David Watson, attorney-in-fact for Timothy Sullivan

Key filing fact

Timothy Eugene Sullivan filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 03 May 2023.

Key facts

This page summarizes Timothy Eugene Sullivan's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 May 2023, 16:22.

Change

Previous filing in this sequence was filed on 20 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APLS transaction

Common Stock

Gift

Transaction value: $0
Shares: -20,000
Change %: -20%
Price: $0.000000
Shares after: 77,713
Date: 03 May 2023
Ownership: Direct

APLS transaction

Common Stock

Gift

Transaction value: $0
Shares: +20,000
Change %: +55%
Price: $0.000000
Shares after: 56,232
Date: 03 May 2023
Ownership: Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023)
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On May 3, 2023, the reporting person transferred 20,000 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.